Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Maravai LifeSciences (MRVI)

Maravai LifeSciences Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MRVI
DateTimeSourceHeadlineSymbolCompany
13/05/202413:00Business WireTriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation CenterNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/05/202421:44Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/05/202421:05GlobeNewswire Inc.Maravai LifeSciences Announces May and June 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
08/05/202421:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
08/05/202421:05GlobeNewswire Inc.Maravai LifeSciences Reports First Quarter 2024 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
30/04/202421:49Business WireTriLink BioTechnologies® et Lonza signent un contrat de licence et d'approvisionnement non exclusif pour la technologie de capsulage d'ARNm CleanCap®NASDAQ:MRVIMaravai LifeSciences Holdings Inc
30/04/202421:49Business WireTriLink BioTechnologies® und Lonza schließen nicht-exklusiven Lizenz- und Liefervertrag für CleanCap® mRNA Capping Technologie abNASDAQ:MRVIMaravai LifeSciences Holdings Inc
30/04/202412:31Business WireTriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping TechnologyNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/04/202420:12Business WireTriLink BioTechnologies® annonce un nouveau site à San Diego pour la production de substances médicamenteuses à base d'ARNm au stade ultime de leur développementNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/04/202420:09Business WireTriLink BioTechnologies® kündigt neue Anlage in San Diego zur mRNA-Produktion von Arzneimittelwirkstoffen in der Spätphase anNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/04/202412:36Business WireTriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance ProductionNASDAQ:MRVIMaravai LifeSciences Holdings Inc
10/04/202421:05GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
12/03/202420:15GlobeNewswire Inc.Maravai LifeSciences Announces March 2024 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
29/02/202422:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
22/02/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
22/02/202421:05GlobeNewswire Inc.Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:MRVIMaravai LifeSciences Holdings Inc
21/02/202413:00Business WireTriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and CanadaNASDAQ:MRVIMaravai LifeSciences Holdings Inc
20/02/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
13/02/202413:30GlobeNewswire Inc.Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in BiomanufacturingNASDAQ:MRVIMaravai LifeSciences Holdings Inc
08/02/202421:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
29/01/202413:00GlobeNewswire Inc.Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024NASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/01/202423:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/01/202423:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/01/202423:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/01/202423:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
18/01/202423:15Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
16/11/202322:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MRVIMaravai LifeSciences Holdings Inc
09/11/202313:15GlobeNewswire Inc.Maravai LifeSciences Announces November 2023 Investor Conference ScheduleNASDAQ:MRVIMaravai LifeSciences Holdings Inc
08/11/202322:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MRVIMaravai LifeSciences Holdings Inc
07/11/202321:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MRVIMaravai LifeSciences Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:MRVI